NEW YORK (GenomeWeb News) – Genomic services startup Personalis today said that it completed the Illumina CSPro certification for sequencing on the HiSeq and MiSeq platforms.
Illumina CSPro is a collaborative service provider partnership. Participants go through a two-phase certification process, which includes data generation, data certification, and an on-site audit of the company's facility and processes.
Personalis CEO John West said in a statement, "Our deep knowledge of the Illumina technology platform allows us to provide an end-to-end service that meets the needs of researchers in academia, pharma, and clinicians."
Personalis is based in Menlo Park, Calif., and provides medical interpretation of human genomes for research purposes. The company was founded in 2011 and launched its genome services in February after securing an exclusive license to commercialize the Pharmacogenomics Knowledge Base, a database links genetic variation with drug metabolism and adverse events.
In March, it said it was awarded a contract by the US Department of Veterans Affairs to provide sequencing and data analysis to the agency.